Hospital
JFK Memorial Hospital, INC.
JFK Memorial Hospital, INC. was paid $61.66M by Medicaid between Jan 2018 and Dec 2024, across 261 billing codes. Its largest line is 0450, Emergency room services — 41% of everything it billed.
33Billing provider infoJFK MEMORIAL HOSPITAL, INC.
INDIO, CA 92201
INDIO, CA 92201
33aNPI1477584993assigned 07/05/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$61.66M
24GClaims1,098,919
24DCodes billed261
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#49 of 410
Median peer was paid$6.90M
This provider vs. median8.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 137,228 | $7.00M | |
| 2019 | 170,481 | $8.63M | |
| 2020 | 126,879 | $7.24M | |
| 2021 | 144,755 | $8.52M | |
| 2022 | 170,621 | $10.52M | |
| 2023 | 179,300 | $10.40M | |
| 2024incomplete | 169,655 | $9.36M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 41% | 105,589 | 91,533 | $25.20M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 72,325 | 64,794 | $20.43M |
| L8699 | Prosthetic implant, not otherwise specified | 4.6% | 727 | 717 | $2.83M |
| J7120 | Ringers lactate infusion, up to 1000 cc | 2.1% | 7,579 | 6,545 | $1.32M |
| J7030 | Infusion, normal saline solution , 1000 cc | 2.0% | 23,076 | 20,655 | $1.24M |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 1.4% | 10,175 | 9,827 | $839K |
| Z7502 | 1.0% | 16,612 | 16,272 | $627K | |
| 99221 | <1% | 3,873 | 3,841 | $615K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 16,276 | 15,129 | $568K |
| 99499 | <1% | 5,661 | 4,791 | $435K | |
| 0360 | <1% | 3,602 | 1,977 | $422K | |
| 0750 | <1% | 2,241 | 2,205 | $344K |
249 more codes
| 59025 | Fetal non-stress test | <1% | 5,380 | $303K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 3,681 | $299K |
| J3490 | Unclassified drugs | <1% | 32,029 | $229K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 9,619 | $209K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 6,700 | $200K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 4,974 | $176K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 7,405 | $173K |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 2,291 | $168K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 28,188 | $164K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 4,573 | $150K |
| J2704 | Injection, propofol, 10 mg | <1% | 5,592 | $147K |
| 0710 | <1% | 5,011 | $143K | |
| 99285 | Emergency room visit (most serious) | <1% | 2,698 | $139K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 16,994 | $138K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,775 | $138K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 66,136 | $127K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 4,320 | $123K |
| Z9725 | <1% | 3,325 | $120K | |
| 99284 | Emergency room visit (serious) | <1% | 2,836 | $108K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 11,935 | $107K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 2,464 | $103K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 225 | $101K |
| 99218 | <1% | 636 | $101K | |
| 88342 | <1% | 2,574 | $98K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 1,638 | $98K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 4,651 | $92K |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 360 | $88K |
| 80053 | Comprehensive metabolic panel | <1% | 36,247 | $85K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 4,510 | $84K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,719 | $84K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 2,480 | $78K |
| 97802 | <1% | 867 | $77K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 5,544 | $76K |
| 0761 | <1% | 1,982 | $73K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 2,255 | $73K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 12,712 | $72K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 4,618 | $66K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 26,415 | $64K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 14,783 | $64K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 16,129 | $63K |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 1,507 | $62K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 9,646 | $55K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 484 | $51K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 6,075 | $49K |
| 71045 | Radiologic examination, chest; single view | <1% | 20,239 | $48K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 4,292 | $48K |
| Z7610 | <1% | 3,318 | $45K | |
| 88313 | <1% | 2,237 | $44K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 8,706 | $41K |
| 84703 | <1% | 24,311 | $41K | |
| 90715 | <1% | 2,729 | $41K | |
| 0272 | <1% | 1,869 | $41K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 941 | $41K |
| 99070 | <1% | 36,311 | $37K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 801 | $36K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 24,012 | $35K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 5,615 | $33K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 798 | $32K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 563 | $30K |
| Q4131 | Epifix or epicord, per square centimeter | <1% | 16 | $26K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 9,516 | $25K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 8,927 | $24K |
| A4217 | Sterile water/saline, 500 ml | <1% | 3,648 | $23K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 5,871 | $22K |
| 99217 | <1% | 751 | $21K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 330 | $21K |
| 80306 | <1% | 5,514 | $20K | |
| 76801 | <1% | 2,946 | $20K | |
| 72131 | <1% | 961 | $19K | |
| 70486 | <1% | 806 | $19K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,908 | $19K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 8,495 | $18K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 634 | $18K |
| 85730 | <1% | 8,526 | $17K | |
| 82962 | <1% | 11,275 | $16K | |
| 99403 | <1% | 202 | $16K | |
| 83690 | <1% | 20,476 | $16K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,578 | $15K |
| 97803 | <1% | 577 | $15K | |
| 88304 | <1% | 1,253 | $15K | |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | <1% | 98 | $13K |
| 88341 | <1% | 121 | $13K | |
| 85610 | <1% | 9,204 | $13K | |
| 84484 | <1% | 11,176 | $13K | |
| 99401 | <1% | 838 | $12K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 268 | $12K |
| 73130 | <1% | 2,198 | $12K | |
| 12001 | <1% | 2,137 | $12K | |
| 81001 | <1% | 26,166 | $12K | |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 148 | $12K |
| 0270 | <1% | 925 | $11K | |
| 12011 | <1% | 1,461 | $11K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 554 | $11K |
| 73610 | <1% | 2,357 | $11K | |
| 72128 | <1% | 611 | $10K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 7,823 | $10K |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 33 | $10K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,098 | $10K |
| G0378 | Hospital observation service, per hour | <1% | 762 | $9K |
| S0077 | Injection, clindamycin phosphate, 300 mg | <1% | 360 | $9K |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 1,723 | $9K |
| 94664 | <1% | 4,414 | $9K | |
| 73030 | <1% | 1,964 | $9K | |
| 86886 | <1% | 3,712 | $9K | |
| 0762 | <1% | 306 | $9K | |
| 73630 | <1% | 2,256 | $9K | |
| 81003 | <1% | 23,211 | $8K | |
| 73110 | <1% | 1,477 | $8K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 7,966 | $8K |
| 86901 | <1% | 4,998 | $8K | |
| 74018 | <1% | 2,360 | $7K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,648 | $7K |
| J1956 | Injection, levofloxacin, 250 mg | <1% | 49 | $7K |
| 99404 | <1% | 94 | $7K | |
| 76830 | Ultrasound, transvaginal | <1% | 1,111 | $7K |
| 93971 | <1% | 663 | $6K | |
| 84702 | <1% | 4,578 | $6K | |
| 96376 | <1% | 617 | $6K | |
| 73090 | <1% | 1,314 | $6K | |
| 83880 | <1% | 2,243 | $6K | |
| 73562 | <1% | 2,352 | $6K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 622 | $6K |
| 87186 | <1% | 2,641 | $6K | |
| 0250 | <1% | 1,465 | $6K | |
| 87040 | <1% | 2,811 | $6K | |
| 83735 | <1% | 7,583 | $5K | |
| 86900 | <1% | 4,996 | $5K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 948 | $5K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 3,389 | $5K |
| 83605 | <1% | 3,269 | $5K | |
| 73080 | <1% | 938 | $5K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 859 | $5K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 35 | $5K |
| 71250 | <1% | 170 | $5K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 159 | $5K |
| 72100 | <1% | 1,264 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,430 | $4K |
| 47563 | <1% | 25 | $4K | |
| 12002 | <1% | 591 | $4K | |
| 74246 | <1% | 64 | $4K | |
| 29125 | <1% | 1,016 | $4K | |
| 88302 | <1% | 231 | $3K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 247 | $3K |
| 70498 | <1% | 214 | $3K | |
| 87077 | <1% | 2,258 | $3K | |
| 99224 | <1% | 41 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,188 | $3K |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 44 | $2K |
| 72170 | <1% | 920 | $2K | |
| 10060 | <1% | 505 | $2K | |
| 82805 | <1% | 525 | $2K | |
| 73590 | <1% | 1,011 | $2K | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 149 | $2K |
| 70496 | <1% | 94 | $2K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 40 | $2K |
| 80076 | <1% | 2,748 | $2K | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 606 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,076 | $2K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 858 | $2K |
| 73140 | <1% | 730 | $2K | |
| 0001A | <1% | 51 | $2K | |
| 76870 | <1% | 281 | $2K | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 94 | $2K |
| 82550 | <1% | 1,941 | $2K | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 779 | $2K |
| A9150 | Non-prescription drugs | <1% | 380 | $2K |
| 87420 | <1% | 2,683 | $2K | |
| Z7500 | <1% | 44 | $2K | |
| 58558 | <1% | 14 | $1K | |
| J0290 | Injection, ampicillin sodium, 500 mg | <1% | 84 | $1K |
| 93017 | <1% | 50 | $1K | |
| 0271 | <1% | 517 | $1K | |
| 86141 | <1% | 998 | $1K | |
| 85379 | <1% | 1,301 | $1K | |
| 87070 | <1% | 204 | $939.17 | |
| 88312 | <1% | 70 | $910.81 | |
| 96367 | <1% | 139 | $910.19 | |
| 72040 | <1% | 331 | $877.01 | |
| 73060 | <1% | 319 | $847.43 | |
| 73620 | <1% | 165 | $845.68 | |
| 71101 | <1% | 206 | $799.98 | |
| 29515 | <1% | 228 | $752.23 | |
| 85027 | <1% | 382 | $749.86 | |
| V5008 | Hearing screening | <1% | 15 | $701.48 |
| J1815 | Injection, insulin, per 5 units | <1% | 806 | $689.20 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 406 | $622.46 |
| 96368 | <1% | 215 | $590.28 | |
| 70491 | <1% | 37 | $545.30 | |
| 84439 | <1% | 451 | $516.26 | |
| 84100 | <1% | 775 | $509.78 | |
| 0011A | <1% | 12 | $480.00 | |
| 73502 | <1% | 98 | $442.66 | |
| 71010 | <1% | 272 | $441.75 | |
| 29130 | <1% | 113 | $428.58 | |
| 94760 | <1% | 335 | $397.82 | |
| 88307 | <1% | 12 | $359.47 | |
| A9270 | Non-covered item or service | <1% | 2,252 | $352.56 |
| 74022 | <1% | 111 | $333.63 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 1,881 | $323.98 |
| 82077 | <1% | 207 | $313.94 | |
| 84550 | <1% | 610 | $305.43 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 27 | $281.25 |
| 71020 | <1% | 151 | $274.67 | |
| 82009 | <1% | 688 | $227.10 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 27 | $226.00 |
| 80061 | Lipid panel | <1% | 150 | $214.86 |
| 85651 | <1% | 569 | $214.08 | |
| 82270 | <1% | 237 | $206.22 | |
| 85347 | <1% | 514 | $198.91 | |
| 82731 | <1% | 29 | $193.44 | |
| 73552 | <1% | 101 | $186.69 | |
| 82140 | <1% | 64 | $150.74 | |
| 73120 | <1% | 30 | $150.72 | |
| 73564 | <1% | 13 | $123.57 | |
| 82570 | <1% | 290 | $114.21 | |
| 73100 | <1% | 12 | $108.05 | |
| 82728 | <1% | 40 | $105.60 | |
| 82150 | <1% | 16 | $102.66 | |
| 84145 | <1% | 112 | $99.24 | |
| 73600 | <1% | 41 | $94.78 | |
| 80178 | <1% | 163 | $92.70 | |
| J1836 | Injection, metronidazole, 10 mg | <1% | 45 | $90.06 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 94 | $82.90 |
| 84156 | <1% | 286 | $79.38 | |
| J3360 | Injection, diazepam, up to 5 mg | <1% | 45 | $64.88 |
| 74019 | <1% | 35 | $60.51 | |
| 82248 | <1% | 50 | $48.77 | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 45 | $47.28 |
| 73660 | <1% | 25 | $44.97 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 69 | $44.78 |
| 87210 | <1% | 85 | $35.94 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 16 | $34.24 |
| 82746 | <1% | 25 | $33.96 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 131 | $33.66 |
| 82607 | <1% | 25 | $20.31 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 17 | $19.16 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 427 | $15.46 |
| 83540 | <1% | 13 | $9.73 | |
| 29505 | <1% | 16 | $6.86 | |
| 89060 | <1% | 75 | $1.27 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 18 | $0.03 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 298 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 15 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 15 | $0.00 |
| 96150 | 0% | 17 | $0.00 | |
| 84112 | 0% | 16 | $0.00 | |
| 85384 | 0% | 13 | $0.00 | |
| 74000 | 0% | 20 | $0.00 | |
| J0558 | Injection, penicillin g benzathine and penicillin g procaine, 100,000 units | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFISH, JIMMY (CFO)
| Provider | Location | Paid |
|---|---|---|
| Desert Regional Medical Center, INC. | Palm Springs, CA | $117.24M |
| HDMC Holdings, LLC | Joshua Tree, CA | $10.71M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.